FDA Inspection 1140939 — GE Parallel Design Inc
The FDA completed an inspection of GE Parallel Design Inc on March 30, 2021 in Phoenix, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 30, 2021
- Fiscal Year
- 2021
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Phoenix, AZ (United States)
Additional Details
Postmarket Audit Inspections